WallStreetZenWallStreetZen

NASDAQ: BLRX
Biolinerx Ltd Stock Ownership - Who owns Biolinerx?

Insider buying vs selling

Have Biolinerx Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BLRX insiders and whales buy or sell their stock.

BLRX Shareholders

What type of owners hold Biolinerx Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Altium Capital Management LP0.25%2,279,657$3.42MInstitution
Morgan Stanley0.03%256,912$385.37kInstitution
Lpl Financial LLC0.01%117,710$176.57kInstitution
Atria Wealth Solutions Inc0.01%110,366$165.55kInstitution
Renaissance Technologies LLC0.01%106,089$159.13kInstitution
Envestnet Asset Management Inc0.01%98,916$148.37kInstitution
Geode Capital Management LLC0.00%32,026$48.04kInstitution
Advisor Group Holdings Inc0.00%30,953$46.43kInstitution
Two Sigma Securities LLC0.00%24,154$36.23kInstitution
Geneos Wealth Management Inc0.00%23,500$35.25kInstitution

1 of 2

BLRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BLRX0.34%0.00%
SLGL31.36%0.00%
SPRO27.10%61.72%Net Selling
VACC26.61%55.09%Net SellingNet Selling
CGEN12.63%0.00%

Biolinerx Stock Ownership FAQ

Who owns Biolinerx?

Biolinerx (NASDAQ: BLRX) is owned by 0.34% institutional shareholders, 0.00% Biolinerx insiders, and 99.66% retail investors. Altium Capital Management LP is the largest individual Biolinerx shareholder, owning 2.28M shares representing 0.25% of the company. Altium Capital Management LP's Biolinerx shares are currently valued at $3.42M.

If you're new to stock investing, here's how to buy Biolinerx stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.